Viking Therapeutics to attend investor conferences

Viking Therapeutics, Inc. announced its participation in upcoming investor conferences. As a clinical-stage biopharmaceutical company focused on developing novel therapies, Viking Therapeutics will use these events to engage with the investment community. The company's presence at these conferences provides an opportunity to share updates on its pipeline and strategic initiatives. Investors and analysts will likely be looking for insights into the company's progress in its therapeutic development programs.